MAPT and Alzheimer disease: Additionally, we observed changes consistent with AD pathogenesis, including increased levels of Tau phosphorylation, indicated by elevated amounts of Tau-PS202/PT205, Tau-PS262, and Tau-PS199, in the hippocampus of the AD Tg and ADWT mice (Fig. 4b–4d).